Oruka Therapeutics, Inc. (ORKA) Insider Ownership

According to recent filings covering the 90 days ending January 10, 2026, the three most significant insider holders at Oruka Therapeutics are TenPercentOwner Healthcare Capital Partners Iii, L.P. Venrock (4.15Mn shares), Director Funds Management Llc Fairmount (1.13Mn shares), TenPercentOwner Funds, Lp Funicular (548.39K shares).

• Oruka Therapeutics's (ORKA) total shares are held approximately 82.88% by institutional investors, 11.33% by company insiders, and 5.79% by other and public investors.
• As of January 10, 2026, insider ownership at Oruka Therapeutics represents 11.33% of the company's total outstanding shares, comprising approximately 6.24Mn shares out of 55.05Mn outstanding shares.
• During the 90-day period through January 10, 2026, Oruka Therapeutics experienced a 5.65% increased in insider ownership, with total insider shares growing from 5.90Mn to 6.24Mn.
• During the 90-day window concluding January 10, 2026, Chief Medical Officer Joana Goncalves executed the largest insider acquisition at Oruka Therapeutics, purchasing 7.00K shares.
• Chief Operating Officer Laura Lee Sandler was the largest seller at Oruka Therapeutics in the past 90 days, offloading 13.00K shares.